Biological Sciences and Healthcare, part 4

... > Pharmaceutical / biologic product (product) > Medicinal product (product) > Medicinal product categorized by structure > Product containing organic acid and organic acid derivative (product) > Product containing carboxylic acid and carboxylic acid derivative (product) > Product containing carbamate (product) > Physostigmine > Product containing physostigmine in ocular dose form (medicinal product form) > Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form) > Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form) > Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug)

... > Pharmaceutical / biologic product (product) > Medicinal product (product) > Medicinal product categorized by disposition (product) > Enzyme inhibitor (product) > Product containing acetylcholinesterase inhibitor (product) > Reversible anticholinesterase > Physostigmine > Product containing physostigmine in ocular dose form (medicinal product form) > Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form) > Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form) > Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug)

... > Pharmaceutical / biologic product (product) > Medicinal product (product) > Medicinal product categorised by therapeutic role > Anti glaucoma preparation (product) > Product containing physostigmine in ocular dose form (medicinal product form) > Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form) > Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form) > Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug)

... > Pharmaceutical / biologic product (product) > Medicinal product (product) > Medicinal product categorized by structure > Product containing organic acid and organic acid derivative (product) > Product containing carboxylic acid and carboxylic acid derivative (product) > Product containing carbamate (product) > Physostigmine > Physostigmine+pilocarpine (product) > Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form) > Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form) > Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug)

... > Pharmaceutical / biologic product (product) > Medicinal product (product) > Medicinal product categorized by disposition (product) > Enzyme inhibitor (product) > Product containing acetylcholinesterase inhibitor (product) > Reversible anticholinesterase > Physostigmine > Physostigmine+pilocarpine (product) > Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form) > Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form) > Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug)

... > Pharmaceutical / biologic product (product) > Medicinal product (product) > Medicinal product categorized by structure > Nitrogen and nitrogen compound product > Product containing azole > Product containing imidazole > Pilocarpine > Physostigmine+pilocarpine (product) > Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form) > Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form) > Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug)

... > Pharmaceutical / biologic product (product) > Medicinal product (product) > Medicinal product categorized by disposition (product) > Cholinergic receptor stimulating preparation (product) > Product containing muscarinic receptor agonist (product) > Pilocarpine > Physostigmine+pilocarpine (product) > Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form) > Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form) > Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug)

... > Pharmaceutical / biologic product (product) > Medicinal product (product) > Medicinal product categorized by structure > Nitrogen and nitrogen compound product > Product containing azole > Product containing imidazole > Pilocarpine > Pilocarpine-containing product in ocular dose form > Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form) > Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form) > Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug)

... > Pharmaceutical / biologic product (product) > Medicinal product (product) > Medicinal product categorized by disposition (product) > Cholinergic receptor stimulating preparation (product) > Product containing muscarinic receptor agonist (product) > Pilocarpine > Pilocarpine-containing product in ocular dose form > Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form) > Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form) > Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug)

... > Pharmaceutical / biologic product (product) > Medicinal product (product) > Medicinal product categorised by therapeutic role > Anti glaucoma preparation (product) > Pilocarpine-containing product in ocular dose form > Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form) > Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form) > Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug)

... > Pharmaceutical / biologic product (product) > Medicinal product (product) > Medicinal product categorized by structure > Product containing organic acid and organic acid derivative (product) > Product containing carboxylic acid and carboxylic acid derivative (product) > Product containing carbamate (product) > Physostigmine > Physostigmine+pilocarpine (product) > Product containing only physostigmine and pilocarpine (medicinal product) > Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form) > Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug)

... > Pharmaceutical / biologic product (product) > Medicinal product (product) > Medicinal product categorized by disposition (product) > Enzyme inhibitor (product) > Product containing acetylcholinesterase inhibitor (product) > Reversible anticholinesterase > Physostigmine > Physostigmine+pilocarpine (product) > Product containing only physostigmine and pilocarpine (medicinal product) > Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form) > Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug)

... > Pharmaceutical / biologic product (product) > Medicinal product (product) > Medicinal product categorized by structure > Nitrogen and nitrogen compound product > Product containing azole > Product containing imidazole > Pilocarpine > Physostigmine+pilocarpine (product) > Product containing only physostigmine and pilocarpine (medicinal product) > Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form) > Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug)

... > Pharmaceutical / biologic product (product) > Medicinal product (product) > Medicinal product categorized by disposition (product) > Cholinergic receptor stimulating preparation (product) > Product containing muscarinic receptor agonist (product) > Pilocarpine > Physostigmine+pilocarpine (product) > Product containing only physostigmine and pilocarpine (medicinal product) > Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form) > Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug)